Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024

細胞培養の世界市場予測(~2024年):消耗品(メディア、FBS)、機器(バイオリアクター、遠心分離機、インキュベーター、顕微鏡、オートクレーブ)

◆タイトル:Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024
◆商品コード:BT 2561
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年7月8日
◆ページ数:235
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別(消耗品(メディア、FBS)、機器(バイオリアクター、遠心分離機、インキュベーター、顕微鏡、オートクレーブ))分析、用途別(幹細胞、ワクチン、治療用タンパク質)分析、エンドユーザー別(製薬、研究機関)分析、細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Increasing funding for cell-based research, growing benefits of the cell culture-based vaccines, and rising demand for monoclonal antibodies are expected to drive the overall growth of the cell culture market.”The cell culture market is expected to reach USD 29.2 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 12.7% during the forecast period. This market is experiencing significant growth due to the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, growing focus on personalized medicine, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.

“Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period.”
Based on end user, the cell culture market is segmented into research institutes, pharmaceutical & biotechnology companies, cell banks, and hospitals & diagnostic laboratories. In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for pharmaceutical and biotechnology companies.
“Biopharmaceutical production to witness the highest growth in the cell culture market.”
Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is also expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increasing demand for monoclonal antibodies (mAbs).

“North America to dominate the market during the forecast period.”
Geographically, the cell culture market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology and pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, strong government support, and conferences and symposiums that create awareness on the latest trends in cell culture technology are the key factors driving the growth of the cell culture market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation – C-level: 33%, D-level: 40%, and Others: 27%
• By Region – North America: 36%, Europe: 28%, Asia Pacific: 19%, Rest of the World: 17%

List of Companies Profiled in the Report
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• GE Healthcare (US)
• Lonza (Switzerland)
• Becton, Dickinson and Company (US)
• Corning Incorporated (US)
• Eppendorf AG (Germany)
• HiMedia Laboratories (India)
• Sartorius AG (Germany)
• PromoCell GmbH (Germany)
• Danaher Corporation (US)
• FUJIFILM Irvine Scientific (US)
• InvivoGen (US)
• CellGenix GmbH (Germany)
• Miltenyi Biotec (Germany)

Research Coverage:
This report provides a detailed picture of the global cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 23
1.4 CURRENCY 23
1.5 LIMITATION 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 SECONDARY DATA 25
2.2.1 SECONDARY SOURCE 25
2.3 PRIMARY DATA 26
2.3.1 KEY DATA FROM PRIMARY SOURCES 26
2.4 MARKET SIZE ESTIMATION 27
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.6 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 35
4.1 CELL CULTURE: MARKET OVERVIEW 35
4.2 ASIA PACIFIC: CELL CULTURE MARKET SHARE, BY END USER AND COUNTRY (2019) 36
4.3 CELL CULTURE SERA, MEDIA, & REAGENTS MARKET, BY TYPE (USD BILLION) 37
4.4 CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION) 38
4.5 CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION) 38
4.6 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 MARKET DRIVERS 41
5.2.1.1 Growing awareness about the benefits of cell culture-based vaccines 41
5.2.1.2 Increasing demand for monoclonal antibodies 41
5.2.1.3 Funding for cell-based research 42
5.2.1.4 Growing preference for single-use technologies 43
5.2.1.5 Launch of advanced cell culture products 43
5.2.1.6 Growing focus on personalized medicine 43
5.2.2 MARKET RESTRAINTS 44
5.2.2.1 High cost of cell biology research 44
5.2.2.2 Lack of infrastructure for cell-based research in emerging economies 44
5.2.3 MARKET OPPORTUNITIES 44
5.2.3.1 Growing demand for 3D cell culture 44
5.2.3.2 Increased risk of pandemics and communicable diseases 45
5.2.3.3 Emerging economies 45
6 CELL CULTURE MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 CONSUMABLES 48
6.2.1 SERA, MEDIA, AND REAGENTS 49
6.2.1.1 Media 50
6.2.1.1.1 Serum-free media 51
6.2.1.1.1.1 Lack of sera eliminates the risk of contamination by viruses 51
6.2.1.1.2 Classical media & salts 51
6.2.1.1.2.1 Classical media is commonly used in diagnostics and manufacturing 51
6.2.1.1.3 Stem cell culture media 52
6.2.1.1.3.1 Stem cell culture media will witness the highest growth in the APAC market 52
6.2.1.1.4 Specialty media 53
6.2.1.1.4.1 Specialty media is suitable for specific, selective cell types 53
6.2.1.2 Reagents 54
6.2.1.2.1 Supplements & growth factors 55
6.2.1.2.1.1 Supplements such as amino acids play a key role in inducing cell growth 55
6.2.1.2.2 Buffers & chemicals 55
6.2.1.2.2.1 Chemical buffers are widely used, but are expensive and can be toxic 55
6.2.1.2.3 Cell dissociation reagents 56
6.2.1.2.3.1 Dissociation reagents can be enzymatic or non-enzymatic 56
6.2.1.2.4 Balanced salt solutions 57
6.2.1.2.4.1 Salt solutions find wide applications in life sciences 57
6.2.1.2.5 Attachment & matrix factors 58
6.2.1.2.5.1 Development of cells is dependent on attachment factors 58
6.2.1.2.6 Antibiotics/Antimycotics 58
6.2.1.2.6.1 Possibility of toxicity and contamination risks make long-term use of antibiotics/antimycotics conditional 58
6.2.1.2.7 Contamination detection kits 59
6.2.1.2.7.1 Kits provide results in hours, much faster than direct culture methods 59
6.2.1.2.8 Cryoprotective reagents 60
6.2.1.2.8.1 Inorganic expansions are a favored strategy for companies in this market 60
6.2.1.2.9 Other cell culture reagents 61
6.2.1.3 Sera 61
6.2.1.3.1 Fetal bovine sera 62
6.2.1.3.1.1 Use of FBS is associated with ethical issues 62
6.2.1.3.2 Adult bovine sera 63
6.2.1.3.2.1 ABS is used as a biochemical agent in IVD 63
6.2.1.3.3 Other animal sera 64
6.2.2 VESSELS 64
6.2.2.1 Roller/roux bottles 65
6.2.2.1.1 Roller bottles offer an economical means of cultivating large cell volumes 65
6.2.2.2 Cell factory systems/cell stacks 66
6.2.2.2.1 Cell stacks require special handling equipment and skilled expertise 66
6.2.2.3 Multiwell plates 66
6.2.2.3.1 Larger well formats allow for greater culture volumes 66
6.2.2.4 Flasks 67
6.2.2.4.1 Disposable flasks are in greater demand among end users 67
6.2.2.5 Petri dishes 68
6.2.2.5.1 Wide usage of Petri dishes is attributed to their ease of use 68
6.2.3 BIOREACTOR ACCESSORIES 68
6.3 EQUIPMENT 69
6.3.1 SUPPORTING EQUIPMENT 70
6.3.1.1 Filtration systems 71
6.3.1.1.1 Growing research in cell biology is a key factor driving market growth 71
6.3.1.2 Cell counters 72
6.3.1.2.1 Automated cell counters are witnessing growing demand 72
6.3.1.3 Carbon dioxide incubators 73
6.3.1.3.1 Incubators provide control over atmospheric conditions for best effect 73
6.3.1.4 Centrifuges 73
6.3.1.4.1 Technological advances have enabled the development of faster, more effective centrifuges 73
6.3.1.5 Autoclaves 74
6.3.1.5.1 Autoclaves sterilize equipment and supplies for use 74
6.3.1.6 Microscopes 75
6.3.1.6.1 Inverted microscopes are widely used in cell culture processes 75
6.3.1.7 Biosafety cabinets 75
6.3.1.7.1 Cabinets are classified into three classes based on protection offered 75
6.3.1.8 Other supporting equipment 76
6.3.2 BIOREACTORS 77
6.3.2.1 Conventional bioreactors 78
6.3.2.1.1 Conventional bioreactors hold the largest share of the bioreactors market 78
6.3.2.2 Single-use bioreactors 79
6.3.2.2.1 Convenience, ease of use, and flexibility are driving demand for single-use bioreactors 79
6.3.3 STORAGE EQUIPMENT 80
6.3.3.1 Refrigerators & freezers 81
6.3.3.1.1 Refrigerators & freezers are used for both short and long-term storage 81
6.3.3.2 Cryostorage systems 82
6.3.3.2.1 Benefits of long-term preservation of cell cultures are driving market growth 82
7 CELL CULTURE MARKET, BY APPLICATION 83
7.1 INTRODUCTION 84
7.2 BIOPHARMACEUTICAL PRODUCTION 85
7.2.1 THERAPEUTIC PROTEINS 86
7.2.1.1 Growing applications of recombinant proteins to drive this segment 86
7.2.2 VACCINE PRODUCTION 87
7.2.2.1 Rising incidence of disease outbreaks to drive the market for vaccine production 87
7.3 DIAGNOSTICS 88
7.3.1 CELL CULTURES ARE USED IN THE DIAGNOSIS OF VIRAL DISEASES 88
7.4 DRUG SCREENING AND DEVELOPMENT 88
7.5 STEM CELL RESEARCH 89
7.5.1 STRINGENT REGULATIONS TO CONDUCT CLINICAL TRIALS FOR NEW STEM CELL-BASED THERAPIES ON HUMAN SUBJECTS IS RESTRAINING THE GROWTH OF THIS SEGMENT 89
7.6 TISSUE ENGINEERING & REGENERATIVE MEDICINE 90
7.7 OTHER APPLICATIONS 90
8 CELL CULTURE MARKET, BY END USER 92
8.1 INTRODUCTION 93
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 94
8.2.1 INCREASING USE OF SINGLE-USE TECHNOLOGIES IS DRIVING THE GROWTH OF THE CELL CULTURE MARKET FOR THIS SEGMENT 94
8.3 HOSPITALS AND DIAGNOSTIC LABORATORIES 95
8.3.1 INCREASING AWARENESS FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THIS SEGMENT 95

8.4 RESEARCH INSTITUTES 95
8.4.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH PROJECTS AND HIGH PREVALENCE OF CANCER TO DRIVE THE CELL CULTURE MARKET FOR RESEARCH INSTITUTES 95
8.5 CELL BANKS 96
8.5.1 INCREASING AWARENESS OF PRESERVING STEM CELLS TO DRIVE THIS SEGMENT 96
9 CELL CULTURE MARKET, BY REGION 98
9.1 INTRODUCTION 99
9.2 NORTH AMERICA 99
9.2.1 US 107
9.2.1.1 US to dominate the North American cell culture market 107
9.2.2 CANADA 113
9.2.2.1 Advancement in the field of regenerative medicine to drive the cell culture market in Canada 113
9.3 EUROPE 119
9.3.1 GERMANY 126
9.3.1.1 Increasing investment by various key players and growing funding from government organizations to drive the market 126
9.3.2 FRANCE 129
9.3.2.1 Support from government and private investors to drive the market for cell culture in France 129
9.3.3 UK 131
9.3.3.1 Growth in the life science industry to drive the market for cell culture in the UK 131
9.3.4 ITALY 134
9.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell culture products 134
9.3.5 SPAIN 137
9.3.5.1 Increasing funding from private and public organizations to aid market growth 137
9.3.6 ROE 139
9.4 ASIA PACIFIC 142
9.4.1 JAPAN 149
9.4.1.1 Strategic developments by companies to drive the market for cell culture in Japan 149
9.4.2 CHINA 152
9.4.2.1 Government initiatives and strategic initiatives by key players to strengthen the biotechnology industry in China 152
9.4.3 INDIA 155
9.4.3.1 Growth initiatives to promote life science industry to drive the market for cell culture in India 155
9.4.4 ROAPAC 157
9.5 REST OF THE WORLD (ROW) 161
10 COMPETITIVE LANDSCAPE 169
10.1 OVERVIEW 169
10.2 MARKET SHARE ANALYSIS, 2018 171
10.3 COMPETITIVE SCENARIO 172
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016–2019) 172
10.3.2 PRODUCT LAUNCHES (2016–2019) 173
10.3.3 EXPANSIONS (2016–2019) 173
10.3.4 ACQUISITIONS (2016–2019) 174
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 175
10.4.1 VENDOR INCLUSION CRITERIA 175
10.4.2 VANGUARDS 175
10.4.3 INNOVATORS 175
10.4.4 DYNAMIC PLAYERS 175
10.4.5 EMERGING PLAYERS 176
11 COMPANY PROFILES 177
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 BECTON, DICKINSON AND COMPANY 177
11.2 CELLGENIX 179
11.3 CORNING 181
11.4 DANAHER 184
11.5 EPPENDORF 187
11.6 FUJIFILM IRVINE SCIENTIFIC (ACQUIRED BY FUJIFILM CORPORATION) 190
11.7 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 193
11.8 HI-MEDIA LABORATORIES 198
11.9 INVIVOGEN 203
11.10 LONZA GROUP AG 204
11.11 MERCK KGAA 209
11.12 MILTENYI BIOTEC 215
11.13 PROMOCELL 217
11.14 SARTORIUS AG 218
11.15 THERMO FISHER SCIENTIFIC 221
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 226
12.1 INSIGHTS FROM INDUSTRY EXPERTS 226
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
12.3 DISCUSSION GUIDE 229
12.4 RELATED REPORTS 233
12.5 AUTHOR DETAILS 234

LIST OF TABLES

TABLE 1 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA 41
TABLE 2 APPROVED MONOCLONAL ANTIBODIES BY EMA/FDA FOR THERAPEUTIC USE 42
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES 44
TABLE 4 CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 48
TABLE 5 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 48
TABLE 6 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 7 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 49
TABLE 8 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION) 50
TABLE 10 CELL CULTURE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 11 SERUM-FREE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 12 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 13 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 14 SPECIALTY MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 15 CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 54
TABLE 16 CELL CULTURE REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 17 SUPPLEMENTS AND GROWTH FACTORS MARKET, BY REGION,
2017–2024 (USD MILLION) 55
TABLE 18 BUFFERS & CHEMICALS MARKET, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 19 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 20 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 21 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION,
2017–2024 (USD MILLION) 58
TABLE 22 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 23 CONTAMINATION DETECTION KITS MARKET, BY REGION,
2017–2024 (USD MILLION) 59
TABLE 24 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 25 OTHER CELL CULTURE REAGENTS MARKET, BY REGION,
2017–2024 (USD MILLION) 61
TABLE 26 CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 27 CELL CULTURE SERA MARKET, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 28 FETAL BOVINE SERA MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 29 ADULT BOVINE SERA MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 30 OTHER ANIMAL SERA MARKET, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 31 VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION) 64
TABLE 32 VESSELS MARKET, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 33 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 34 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION,
2017–2024 (USD MILLION) 66
TABLE 35 MULTIWELL PLATES MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 36 FLASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 37 PETRI DISHES MARKET, BY REGION, 2017–2024 (USD MILLION) 68
TABLE 38 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 68
TABLE 39 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 69
TABLE 40 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 41 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 70
TABLE 42 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION,
2017–2024 (USD MILLION) 70
TABLE 43 FILTRATION SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 44 CELL COUNTERS MARKET, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 45 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2017–2024 (USD MILLION) 73
TABLE 46 CENTRIFUGES MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 47 AUTOCLAVES MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 48 MICROSCOPES MARKET, BY REGION, 2017–2024 (USD MILLION) 75
TABLE 49 BIOSAFETY CABINETS MARKET, BY REGION, 2017–2024 (USD MILLION) 76
TABLE 50 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION,
2017–2024 (USD MILLION) 77
TABLE 51 CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 52 CELL CULTURE BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 53 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 54 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 55 CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 80
TABLE 56 CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION,
2017–2024 (USD MILLION) 80
TABLE 57 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2017–2024 (USD MILLION) 81
TABLE 58 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION) 82
TABLE 59 CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 84
TABLE 60 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE,
2017–2024 (USD MILLION) 85
TABLE 61 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 62 THERAPEUTIC PROTEINS MARKET, BY REGION, 2018-2023 (USD MILLION) 86
TABLE 63 VACCINE PRODUCTION MARKET, BY REGION, 2017–2024 (USD MILLION) 87
TABLE 64 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION,
2017–2024 (USD MILLION) 88
TABLE 65 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2017–2024 (USD MILLION) 88
TABLE 66 CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY REGION,
2017–2024 (USD MILLION) 89
TABLE 67 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2017–2024 (USD MILLION) 90
TABLE 68 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 91
TABLE 69 CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 93
TABLE 70 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 94
TABLE 71 CELL CULTURE MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,
BY REGION, 2017–2024 (USD MILLION) 95
TABLE 72 CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION,
2017–2024 (USD MILLION) 96
TABLE 73 CELL CULTURE MARKET FOR CELL BANKS, BY REGION,
2017–2024 (USD MILLION) 97
TABLE 74 CELL CULTURE MARKET, BY REGION, 2017–2024 (USD MILLION) 99
TABLE 75 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 101
TABLE 76 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 101
TABLE 77 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 78 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 102
TABLE 79 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,
2017–2024 (USD MILLION) 102
TABLE 80 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 103
TABLE 81 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE,
2017–2024 (USD MILLION) 103
TABLE 82 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,
2017–2024 (USD MILLION) 104
TABLE 83 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 104
TABLE 84 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY TYPE, 2017–2024 (USD MILLION) 105
TABLE 85 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 105
TABLE 86 NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2017–2024 (USD MILLION) 106
TABLE 87 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 106
TABLE 88 NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 106
TABLE 89 NORTH AMERICA: CELL CULTURE MARKET, BY END USER,
2017–2024 (USD MILLION) 107
TABLE 90 US: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 108
TABLE 91 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 92 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 108
TABLE 93 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 94 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 95 US: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 96 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 97 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 98 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 111
TABLE 99 US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 111
TABLE 100 US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION) 111
TABLE 101 US: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 112
TABLE 102 US: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE,
2017–2024 (USD MILLION) 112
TABLE 103 US: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 113
TABLE 104 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 114
TABLE 105 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 114
TABLE 106 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 114
TABLE 107 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION) 115
TABLE 108 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 115
TABLE 109 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 116
TABLE 110 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION) 116
TABLE 111 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 116
TABLE 112 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 117
TABLE 113 CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 117
TABLE 114 CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2017–2024 (USD MILLION) 117
TABLE 115 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 118
TABLE 116 CANADA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 118
TABLE 117 CANADA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 119
TABLE 118 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 121
TABLE 119 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 121
TABLE 120 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 121 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 122
TABLE 122 EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2017–2024 (USD MILLION) 122
TABLE 123 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 122
TABLE 124 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 123
TABLE 125 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 123
TABLE 126 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 127 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 124
TABLE 128 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 124
TABLE 129 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 130 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 125
TABLE 131 EUROPE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 132 EUROPE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 126
TABLE 133 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 127
TABLE 134 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 135 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 136 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 128
TABLE 137 GERMANY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 138 GERMANY: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 128
TABLE 139 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 129
TABLE 140 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 141 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 142 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 130
TABLE 143 FRANCE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 144 FRANCE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 131
TABLE 145 UK: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 132
TABLE 146 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 147 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 133
TABLE 148 UK: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 133
TABLE 149 UK: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE,
2017–2024 (USD MILLION) 133
TABLE 150 UK: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 134
TABLE 151 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 135
TABLE 152 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 135
TABLE 153 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 135
TABLE 154 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 136
TABLE 155 ITALY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 156 ITALY: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 136
TABLE 157 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 137
TABLE 158 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 137
TABLE 159 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 138
TABLE 160 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 138
TABLE 161 SPAIN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION) 139
TABLE 162 SPAIN: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 139
TABLE 163 ROE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 140
TABLE 164 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 140
TABLE 165 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 140
TABLE 166 ROE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 141
TABLE 167 ROE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION) 141
TABLE 168 ROE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 142
TABLE 169 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 142
TABLE 170 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 143
TABLE 171 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 144
TABLE 172 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 144
TABLE 173 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE,
2017–2024 (USD MILLION) 145
TABLE 174 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 145
TABLE 175 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 146
TABLE 176 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE,
2017–2024 (USD MILLION) 146
TABLE 177 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 146
TABLE 178 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 147
TABLE 179 ASIA PACIFIC: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2017–2024 (USD MILLION) 147
TABLE 180 ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 148
TABLE 181 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 148
TABLE 182 ASIA PACIFIC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 148
TABLE 183 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 149
TABLE 184 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 150
TABLE 185 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 150
TABLE 186 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 150
TABLE 187 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 151
TABLE 188 JAPAN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 151
TABLE 189 JAPAN: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 151
TABLE 190 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 152
TABLE 191 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 153
TABLE 192 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 153
TABLE 193 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 153
TABLE 194 CHINA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 154
TABLE 195 CHINA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 154
TABLE 196 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 155
TABLE 197 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 156
TABLE 198 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 156
TABLE 199 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 156
TABLE 200 INDIA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION) 157
TABLE 201 INDIA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 157
TABLE 202 ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 158
TABLE 203 ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 159
TABLE 204 ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 159
TABLE 205 ROAPAC: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 159
TABLE 206 ROAPAC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 160
TABLE 207 ROAPAC: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 160
TABLE 208 ROW: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 163
TABLE 209 ROW: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 163
TABLE 210 ROW: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 163
TABLE 211 ROW: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION) 164
TABLE 212 ROW: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 164
TABLE 213 ROW: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION) 165
TABLE 214 ROW: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION) 165
TABLE 215 ROW: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION) 165
TABLE 216 ROW: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 166
TABLE 217 ROW: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2017–2024 (USD MILLION) 166
TABLE 218 ROW: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 166
TABLE 219 ROW: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 167
TABLE 220 ROW: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET,
BY TYPE, 2017–2024 (USD MILLION) 167
TABLE 221 ROW: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION) 168
TABLE 222 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 188
TABLE 223 EXCHANGE RATES (USED FOR THE CONVERSION OF JPY YEN TO USD) 191
TABLE 224 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 210


LIST OF FIGURES

FIGURE 1 CELL CULTURE MARKET 22
FIGURE 2 RESEARCH DESIGN 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 27
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 28
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 28
FIGURE 6 DATA TRIANGULATION METHODOLOGY 29
FIGURE 7 CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION) 31
FIGURE 8 CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION) 32
FIGURE 9 CELL CULTURE MARKET, BY END USER (USD BILLION) 33
FIGURE 10 GEOGRAPHICAL SNAPSHOT: CELL CULTURE MARKET 34
FIGURE 11 CELL CULTURE MARKET TO WITNESS DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD 35
FIGURE 12 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC CELL CULTURE MARKET IN 2019 36
FIGURE 13 CELL CULTURE MEDIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37
FIGURE 14 THE BIOPHARMACEUTICAL PRODUCTION SEGMENT IS PROJECTED TO DOMINATE THE CELL CULTURE MARKET IN 2024 38
FIGURE 15 CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 17 CELL CULTURE MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES 40
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE CELL CULTURE PRODUCTS MARKET IN 2019 47
FIGURE 19 BIOPHARMACEUTICAL PRODUCTION SEGMENT TO DOMINATE MARKET DURING THE FORECAST PERIOD 84
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2024 93
FIGURE 21 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT 100
FIGURE 22 EUROPE: CELL CULTURE MARKET SNAPSHOT 120
FIGURE 23 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT 143
FIGURE 24 REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT 162
FIGURE 25 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2016 AND 2019 169
FIGURE 26 MARKET EVOLUTION FRAMEWORK 170
FIGURE 27 GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 171
FIGURE 28 MNM DIVE-VENDOR COMPARISON MATRIX: CELL CULTURE MARKET 176
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 177
FIGURE 30 CORNING: COMPANY SNAPSHOT 181
FIGURE 31 DANAHER: COMPANY SNAPSHOT 184
FIGURE 32 EPPENDORF: COMPANY SNAPSHOT 187
FIGURE 33 FUJIFILM CORPORATION: COMPANY SNAPSHOT 190
FIGURE 34 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 193
FIGURE 35 LONZA GROUP AG: COMPANY SNAPSHOT 204
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT 209
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT 218
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 221


★調査レポート[細胞培養の世界市場予測(~2024年):消耗品(メディア、FBS)、機器(バイオリアクター、遠心分離機、インキュベーター、顕微鏡、オートクレーブ)] ( Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024 / BT 2561) 販売に関する免責事項
[細胞培養の世界市場予測(~2024年):消耗品(メディア、FBS)、機器(バイオリアクター、遠心分離機、インキュベーター、顕微鏡、オートクレーブ)] ( Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024 / BT 2561) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆